129 related articles for article (PubMed ID: 17074643)
1. Andersen-Tawil syndrome: an ever-expanding phenotype?
Tristani-Firouzi M
Heart Rhythm; 2006 Nov; 3(11):1351-2. PubMed ID: 17074643
[No Abstract] [Full Text] [Related]
2. A family with Andersen-Tawil syndrome and dilated cardiomyopathy.
Schoonderwoerd BA; Wiesfeld AC; Wilde AA; van den Heuvel F; Van Tintelen JP; van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Heart Rhythm; 2006 Nov; 3(11):1346-50. PubMed ID: 17074642
[No Abstract] [Full Text] [Related]
3. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
[No Abstract] [Full Text] [Related]
4. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
[TBL] [Abstract][Full Text] [Related]
5. Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome.
Kim JB; Chung KW
Pediatr Neurol; 2009 Dec; 41(6):464-6. PubMed ID: 19931173
[TBL] [Abstract][Full Text] [Related]
6. Andersen-Tawil syndrome, scarier for the doctor than for the patient? Who, when, and how to treat.
Wilde AA
Europace; 2013 Dec; 15(12):1690-2. PubMed ID: 24128811
[No Abstract] [Full Text] [Related]
7. KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.
Obeyesekere MN; Klein GJ; Conacher S; Krahn AD
Can J Cardiol; 2011; 27(6):870.e11-3. PubMed ID: 21875779
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.
Nagase S; Kusano KF; Yoshida M; Ohe T
Heart Rhythm; 2007 Apr; 4(4):512-5. PubMed ID: 17399643
[TBL] [Abstract][Full Text] [Related]
9. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of radiofrequency catheter ablation in Andersen-Tawil syndrome: are we targeting the right spot?
Márquez MF; Nava S; Gómez J; Colín L; Iturralde P
Europace; 2014 Nov; 16(11):1697-8. PubMed ID: 24473499
[No Abstract] [Full Text] [Related]
11. Andersen-Tawil syndrome. A diagnostic challenge.
Reyes Villatoro MA; Márquez MF; Gómez-Flores J; Nava S; Colín L; Iturralde P
Int J Cardiol; 2016 Feb; 205():163-164. PubMed ID: 26736094
[No Abstract] [Full Text] [Related]
12. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
[TBL] [Abstract][Full Text] [Related]
13. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
[No Abstract] [Full Text] [Related]
14. A study supporting possible expression of inward-rectifying potassium channel 2.1 channels in peripheral nerve in a patient with Andersen-Tawil syndrome.
Shibuya K; Tsuneyama A; Beppu M; Misawa S; Sekiguchi Y; Amino H; Suzuki YI; Suichi T; Nakamura K; Kuwabara S
Muscle Nerve; 2019 Apr; 59(4):E28-E30. PubMed ID: 30681175
[No Abstract] [Full Text] [Related]
15. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
16. Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
Bigelow AM; Khalifa MM; Clark JM
Heart Rhythm; 2015 Jul; 12(7):1654-7. PubMed ID: 25814423
[No Abstract] [Full Text] [Related]
17. Coincidence of Andersen-Tawil syndrome and Marfan syndrome: A case report.
Krych M; Ponińska J; Bilińska ZT; Płoski R; Biernacka EK
Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12624. PubMed ID: 30672637
[TBL] [Abstract][Full Text] [Related]
18. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
19. Andersen cardiodysrhythmic periodic paralysis with KCNJ2 mutations: a novel mutation in the pore selectivity filter residue.
Lim BC; Kim GB; Bae EJ; Noh CI; Hwang H; Kim KJ; Hwang YS; Ko TS; Chae JH
J Child Neurol; 2010 Apr; 25(4):490-3. PubMed ID: 20382953
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
Vega AL; Tester DJ; Ackerman MJ; Makielski JC
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):540-7. PubMed ID: 19843922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
